Board of Directors of the Company at its meeting held today approved the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on June 30, 2023

pdf

Shivalik Rasayan Ltd.

08 Aug 2023

421.00

-0.87%

Result

Shivalik Rasayan Ltd - 539148 - Financial Results For The Quarter Ended On 30.06.2023

BSE India

Board of Directors at its meeting held today approved the following business agendas 1.Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 30.06.2023 2. Draft Annual report for the year ended on 31.03.2023 3. Appointed M/s Rahul Chaudhary & Associates as Statutory Auditor of the Company subject to the approval of Members of the Company

pdf

Shivalik Rasayan Ltd.

01 Aug 2023

421.00

-0.87%

Board Meeting

Shivalik Rasayan Ltd - 539148 - Board Meeting Intimation for Consideration & Approval Of Un-Audited Financial …

BSE India

Shivalik Rasayan Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2023 ,inter alia, to consider and approve Un-audited Financial Results for the quarter ended on 30.06.2023

pdf

Shivalik Rasayan Ltd.

28 Jul 2023

421.00

-0.87%

Company Update

Shivalik Rasayan Ltd - 539148 - Filling Of Drug Master File (DMF)

BSE India

we are pleased to inform you that Centre for Drug Evaluation (CDE), China has acknowledged the DMF of Bendamustine API.

pdf

Shivalik Rasayan Ltd.

19 Jul 2023

421.00

-0.87%

Company Update

Shivalik Rasayan Ltd - 539148 - Disclosure Under Regulation 30 Of LODR (Listing Obligations And Disclosure …

BSE India

We wish to inform you that Shivalik Rasayan Limited has issued Letter of Authorisation to Medicamen Biotech Limited to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5 mg/ vial.

pdf